CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease
- PMID: 11528596
- DOI: 10.1086/323155
CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease
Abstract
The pathogenesis of coronary arterial inflammation in acute Kawasaki disease (KD) is unclear. To test the hypothesis that the KD vascular lesion is an activated T lymphocyte-dependent process, immunohistochemical studies were done on coronary artery aneurysms from 8 fatal acute KD cases by using antibodies to CD45RO (activated or memory T lymphocyte), CD8 (cytotoxic T lymphocyte), CD4 (helper T lymphocyte), HAM56 (macrophage), and CD20 (B lymphocyte). Acute KD coronary arteritis was characterized by transmural infiltration of CD45RO T lymphocytes with CD8 T lymphocytes predominating over CD4 T lymphocytes. Macrophages were present primarily in the adventitial layer; B lymphocytes were notably absent. These data lend support to the hypotheses that KD results from infection with an intracellular pathogen, such as a virus, whose antigens are presented by major histocompatibility complex class I molecules, and that CD8 T lymphocytes and macrophages are important in the pathogenesis of KD coronary aneurysms.
Similar articles
-
CD8 T lymphocytes do not express cytotoxic proteins in coronary artery aneurysms in acute Kawasaki disease.Pediatr Infect Dis J. 2005 Apr;24(4):382-4. doi: 10.1097/01.inf.0000157224.25722.76. Pediatr Infect Dis J. 2005. PMID: 15818305
-
Arterial immune protein expression demonstrates the complexity of immune responses in Kawasaki disease arteritis.Clin Exp Immunol. 2017 Nov;190(2):244-250. doi: 10.1111/cei.13010. Epub 2017 Aug 7. Clin Exp Immunol. 2017. PMID: 28707750 Free PMC article.
-
Allograft Inflammatory Factor-1 Links T-Cell Activation, Interferon Response, and Macrophage Activation in Chronic Kawasaki Disease Arteritis.J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e94-e102. doi: 10.1093/jpids/pix025. J Pediatric Infect Dis Soc. 2017. PMID: 28505365 Free PMC article.
-
Histopathological aspects of cardiovascular lesions in Kawasaki disease.Int J Rheum Dis. 2018 Jan;21(1):31-35. doi: 10.1111/1756-185X.13207. Epub 2017 Nov 3. Int J Rheum Dis. 2018. PMID: 29105353 Review.
-
Clinical and immunologic aspects of Kawasaki disease.Immunodefic Rev. 1989;1(3):261-71. Immunodefic Rev. 1989. PMID: 2698643 Review.
Cited by
-
A functional polymorphism, rs28493229, in ITPKC and risk of Kawasaki disease: an integrated meta-analysis.Mol Biol Rep. 2012 Dec;39(12):11137-44. doi: 10.1007/s11033-012-2022-0. Epub 2012 Oct 13. Mol Biol Rep. 2012. PMID: 23065250
-
Diagnostic model based on bioinformatics and machine learning to distinguish Kawasaki disease using multiple datasets.BMC Pediatr. 2022 Aug 30;22(1):512. doi: 10.1186/s12887-022-03557-y. BMC Pediatr. 2022. PMID: 36042431 Free PMC article.
-
ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.Cancers (Basel). 2020 Sep 25;12(10):2758. doi: 10.3390/cancers12102758. Cancers (Basel). 2020. PMID: 32992708 Free PMC article.
-
Infliximab treatment of pancreatitis complicating acute kawasaki disease.Pediatr Infect Dis J. 2012 Oct;31(10):1087-9. doi: 10.1097/INF.0b013e31826108c2. Pediatr Infect Dis J. 2012. PMID: 22653489 Free PMC article.
-
Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm.J Pediatr. 2019 Dec;215:107-117.e12. doi: 10.1016/j.jpeds.2019.07.064. Epub 2019 Sep 24. J Pediatr. 2019. PMID: 31561960 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials